Vidacare Corporation Launches the T.A.L.O.N. Intraosseous Vascular Access System
At the 2013 Military Health System Research Symposium (MHSRS) in Fort Lauderdale, Vidacare Corporation will be launching the T.A.L.O.N.TM (Tactically Advanced Lifesaving Intraosseous Needle) Intraosseous Vascular Access System for military use.
The T.A.L.O.N. system is a groundbreaking single needle solution for vascular access that provides combat life savers and medics with rapid and accurate manual IO access to seven FDA cleared IO sites – proximal tibia (below the knee), distal tibia (ankle), proximal humerus (shoulder) and the sternum. The T.A.L.O.N. system is the first IO system to meet all Committee on Tactical Casualty Care (CoTCC) recommendations for IO devices.
Night Vision Device Market - Global Forecast to 2020
T.A.L.O.N. provides rapid vascular access through the intraosseous (inside the bone) space and helps deliver vital fluids and drugs through this space, the body’s largest non-collapsible vein, to injured soldiers safely and quickly. T.A.L.O.N. is a non-powered vascular access option that complements Vidacare’s powered EZ-IO® Intraosseous Vascular Access System that is widely utilized in combat medicine today.
This system is designed to provide battlefield responders a tactical advantage needed in the combat zone via its lightweight and minimal cube design, proven ability to gain vascular access quickly and safely, and its versatility because no additional intraosseous vascular access gear or tools are needed. As with any vascular access site, the IO insertion site should be monitored frequently and the system should be used only when anatomical landmarks can be clearly identified and in accordance with the T.A.L.O.N. system’s instructions for use.
The T.A.L.O.N. system will be commercially available in the United States starting in early Q4 2013.
“This system is designed specifically to address the needs and concerns of military personnel treating patients under strenuous conditions. The T.A.L.O.N. system will help achieve vascular access and save lives when seconds count. Also its design is ideal for the combat zone,” said Mark Mellin, President and CEO of Vidacare Corporation.
Source : Vidacare Corporation - view original press release
Nov 29 - 30, 2016 - Shrivenham, United Kingdom
Jan 30 - 31, 2017 - Rome, Italy